vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and T1 Energy Inc. (TE). Click either name above to swap in a different company.
T1 Energy Inc. is the larger business by last-quarter revenue ($210.5M vs $168.4M, roughly 1.2× Esperion Therapeutics, Inc.).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Sony Energy Devices Corporation , is a Japanese multinational company specializing in a variety of areas in the energy industry, and is a wholly owned subsidiary and part of the Devices Group of Sony. The company was established in February 1975 in Fukushima, Japan.
ESPR vs TE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $210.5M |
| Net Profit | — | $-130.6M |
| Gross Margin | — | 10.0% |
| Operating Margin | 50.6% | -45.0% |
| Net Margin | — | -62.0% |
| Revenue YoY | 143.7% | — |
| Net Profit YoY | — | -375.2% |
| EPS (diluted) | $0.32 | $-0.87 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | — | ||
| Q3 25 | $87.3M | $210.5M | ||
| Q2 25 | $82.4M | $132.8M | ||
| Q1 25 | $65.0M | $53.5M | ||
| Q4 24 | $69.1M | — | ||
| Q3 24 | $51.6M | $0 | ||
| Q2 24 | $73.8M | $0 | ||
| Q1 24 | $137.7M | $0 |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-130.6M | ||
| Q2 25 | $-12.7M | $-31.9M | ||
| Q1 25 | $-40.5M | $-16.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-27.5M | ||
| Q2 24 | $-61.9M | $-27.0M | ||
| Q1 24 | $61.0M | $-28.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | 10.0% | ||
| Q2 25 | — | 24.7% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 50.6% | — | ||
| Q3 25 | -11.4% | -45.0% | ||
| Q2 25 | 8.6% | -22.0% | ||
| Q1 25 | -34.0% | -44.2% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -31.0% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 52.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -62.0% | ||
| Q2 25 | -15.4% | -24.0% | ||
| Q1 25 | -62.2% | -30.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | — | ||
| Q2 24 | -83.9% | — | ||
| Q1 24 | 44.3% | — |
| Q4 25 | $0.32 | — | ||
| Q3 25 | $-0.16 | $-0.87 | ||
| Q2 25 | $-0.06 | $-0.21 | ||
| Q1 25 | $-0.21 | $-0.11 | ||
| Q4 24 | $-0.14 | — | ||
| Q3 24 | $-0.15 | $-0.20 | ||
| Q2 24 | $-0.33 | $-0.19 | ||
| Q1 24 | $0.34 | $-0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $34.1M |
| Total DebtLower is stronger | — | $547.3M |
| Stockholders' EquityBook value | $-302.0M | $96.9M |
| Total Assets | $465.9M | $1.4B |
| Debt / EquityLower = less leverage | — | 5.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | $34.1M | ||
| Q2 25 | $86.1M | $8.5M | ||
| Q1 25 | $114.6M | $48.9M | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | $181.9M | ||
| Q2 24 | $189.3M | $219.6M | ||
| Q1 24 | $226.6M | $249.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | $547.3M | ||
| Q2 25 | — | $591.2M | ||
| Q1 25 | — | $603.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $602.3M |
| Q4 25 | $-302.0M | — | ||
| Q3 25 | $-451.4M | $96.9M | ||
| Q2 25 | $-433.5M | $183.9M | ||
| Q1 25 | $-426.2M | $201.9M | ||
| Q4 24 | $-388.7M | — | ||
| Q3 24 | $-370.2M | $538.7M | ||
| Q2 24 | $-344.2M | $561.6M | ||
| Q1 24 | $-294.3M | $582.3M |
| Q4 25 | $465.9M | — | ||
| Q3 25 | $364.0M | $1.4B | ||
| Q2 25 | $347.1M | $1.4B | ||
| Q1 25 | $324.0M | $1.4B | ||
| Q4 24 | $343.8M | — | ||
| Q3 24 | $314.1M | $615.0M | ||
| Q2 24 | $352.3M | $644.4M | ||
| Q1 24 | $373.1M | $670.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.65× | ||
| Q2 25 | — | 3.21× | ||
| Q1 25 | — | 2.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 1.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $63.9M |
| Free Cash FlowOCF − Capex | — | $55.0M |
| FCF MarginFCF / Revenue | — | 26.1% |
| Capex IntensityCapex / Revenue | 0.0% | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-42.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | — | ||
| Q3 25 | $-4.3M | $63.9M | ||
| Q2 25 | $-31.4M | $33.4M | ||
| Q1 25 | $-22.6M | $-44.8M | ||
| Q4 24 | $-35.0M | — | ||
| Q3 24 | $-35.3M | $-28.4M | ||
| Q2 24 | $-7.2M | $-28.0M | ||
| Q1 24 | $53.8M | $-16.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | $55.0M | ||
| Q2 25 | — | $10.6M | ||
| Q1 25 | — | $-74.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-35.5M | $-34.0M | ||
| Q2 24 | $-7.3M | $-35.6M | ||
| Q1 24 | $53.8M | $-37.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | 26.1% | ||
| Q2 25 | — | 8.0% | ||
| Q1 25 | — | -138.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | -68.7% | — | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 4.2% | ||
| Q2 25 | 0.0% | 17.2% | ||
| Q1 25 | 0.0% | 54.5% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
TE
| Related Party | $120.1M | 57% |
| Nonrelated Party | $90.4M | 43% |
